{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T22:07:31Z","timestamp":1764540451813,"version":"build-2065373602"},"reference-count":152,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Natural Science Foundation of Zhejiang Province","doi-asserted-by":"publisher","award":["LTGY23H160011"],"award-info":[{"award-number":["LTGY23H160011"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.critrevonc.2023.104012","type":"journal-article","created":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T12:46:45Z","timestamp":1682513205000},"page":"104012","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["LncRNAs and related molecular basis in malignant pleural mesothelioma: Challenges and potential"],"prefix":"10.1016","volume":"186","author":[{"given":"Xiaoling","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huihui","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingying","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zichao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ding","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weimin","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2023.104012_bib1","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.thorsurg.2020.08.005","article-title":"The molecular basis of malignant pleural mesothelioma","volume":"30","author":"Wadowski","year":"2020","journal-title":"Thorac. Surg. Clin."},{"key":"10.1016\/j.critrevonc.2023.104012_bib2","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.thorsurg.2020.08.007","article-title":"Pathology of malignant pleural mesothelioma","volume":"30","author":"Hung","year":"2020","journal-title":"Thorac. Surg. Clin."},{"key":"10.1016\/j.critrevonc.2023.104012_bib3","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.critrevonc.2023.104012_bib4","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nrc.2017.42","article-title":"Novel insights into mesothelioma biology and implications for therapy","volume":"17","author":"Yap","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.critrevonc.2023.104012_bib5","article-title":"How I treat malignant pleural mesothelioma","volume":"4","author":"Viscardi","year":"2020","journal-title":"ESMO Open"},{"key":"10.1016\/j.critrevonc.2023.104012_bib6","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/gtc.12599","article-title":"Critical role of the Ror-family of receptor tyrosine kinases in invasion and proliferation of malignant pleural mesothelioma cells","volume":"23","author":"Saji","year":"2018","journal-title":"Genes Cells"},{"key":"10.1016\/j.critrevonc.2023.104012_bib7","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/pin.13196","article-title":"Asbestos-induced mesothelial injury and carcinogenesis: involvement of iron and reactive oxygen species","volume":"72","author":"Okazaki","year":"2022","journal-title":"Pathol. Int"},{"key":"10.1016\/j.critrevonc.2023.104012_bib8","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1126\/science.1156995","article-title":"Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica","volume":"320","author":"Dostert","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2023.104012_bib9","first-page":"402","article-title":"Mesothelioma: scientific clues for prevention, diagnosis, and therapy","volume":"69","author":"Carbone","year":"2019","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.critrevonc.2023.104012_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13040658","article-title":"Biomarkers for Malignant Pleural Mesothelioma-A Novel View on Inflammation","volume":"13","author":"Vogl","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.critrevonc.2023.104012_bib11","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ctrv.2014.10.007","article-title":"Malignant pleural mesothelioma: new hope in the horizon with novel therapeutic strategies","volume":"41","author":"Remon","year":"2015","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.critrevonc.2023.104012_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2019.102815","article-title":"Emerging therapies in malignant pleural mesothelioma","volume":"144","author":"Cinausero","year":"2019","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.critrevonc.2023.104012_bib13","first-page":"21","article-title":"Genomics and functional genomics of malignant pleural mesothelioma","author":"Cakiroglu","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2023.104012_bib14","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2023.104012_bib15","doi-asserted-by":"crossref","first-page":"e532","DOI":"10.1016\/S1470-2045(17)30459-X","article-title":"Radiotherapy for the treatment of malignant pleural mesothelioma","volume":"18","author":"de Perrot","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2023.104012_bib16","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.2147\/OTT.S317434","article-title":"Advances in immunotherapy of malignant pleural mesothelioma","volume":"14","author":"Liao","year":"2021","journal-title":"Onco Targets Ther."},{"key":"10.1016\/j.critrevonc.2023.104012_bib17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrc.2017.99","article-title":"Non-coding RNA networks in cancer","volume":"18","author":"Anastasiadou","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.critrevonc.2023.104012_bib18","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.canlet.2020.04.023","article-title":"Non-coding RNA in bladder cancer","volume":"485","author":"Li","year":"2020","journal-title":"Cancer Lett."},{"key":"10.1016\/j.critrevonc.2023.104012_bib19","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/s41568-021-00353-1","article-title":"Long noncoding RNAs in cancer metastasis","volume":"21","author":"Liu","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.critrevonc.2023.104012_bib20","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1158\/0008-5472.CAN-16-2634","article-title":"Long noncoding RNA and cancer: a new paradigm","volume":"77","author":"Bhan","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2023.104012_bib21","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1097\/CEJ.0000000000000537","article-title":"Reactive oxygen species-regulating proteins peroxiredoxin 2 and thioredoxin, and glyceraldehyde-3-phosphate dehydrogenase are differentially abundant in induced sputum from smokers with lung cancer or asbestos exposure","volume":"29","author":"Rostila","year":"2020","journal-title":"Eur. J. Cancer Prev."},{"key":"10.1016\/j.critrevonc.2023.104012_bib22","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1289\/ehp.1104287","article-title":"Mitochondria-derived reactive intermediate species mediate asbestos-induced genotoxicity and oxidative stress-responsive signaling pathways","volume":"120","author":"Huang","year":"2012","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.critrevonc.2023.104012_bib23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/15476910802085822","article-title":"The latent form of TGFbeta(1) is induced by TNFalpha through an ERK specific pathway and is activated by asbestos-derived reactive oxygen species in vitro and in vivo","volume":"5","author":"Sullivan","year":"2008","journal-title":"J. Immunotoxicol."},{"key":"10.1016\/j.critrevonc.2023.104012_bib24","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.3389\/fonc.2019.01293","article-title":"Epigenetic regulation of miRNA expression in malignant mesothelioma: miRNAs as biomarkers of early diagnosis and therapy","volume":"9","author":"Tomasetti","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2023.104012_bib25","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.mrrev.2008.02.002","article-title":"Genetic susceptibility to malignant pleural mesothelioma and other asbestos-associated diseases","volume":"659","author":"Neri","year":"2008","journal-title":"Mutat. Res."},{"key":"10.1016\/j.critrevonc.2023.104012_bib26","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/jcp.22724","article-title":"Malignant mesothelioma: facts, myths, and hypotheses","volume":"227","author":"Carbone","year":"2012","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.critrevonc.2023.104012_bib27","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2478\/raon-2018-0004","article-title":"The influence of genetic variability on the risk of developing malignant mesothelioma","volume":"52","author":"Franko","year":"2018","journal-title":"Radio. Oncol."},{"key":"10.1016\/j.critrevonc.2023.104012_bib28","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/JTO.0000000000000471","article-title":"High incidence of somatic BAP1 alterations in sporadic malignant mesothelioma","volume":"10","author":"Nasu","year":"2015","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.critrevonc.2023.104012_bib29","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ng.3520","article-title":"Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations","volume":"48","author":"Bueno","year":"2016","journal-title":"Nat. Genet"},{"key":"10.1016\/j.critrevonc.2023.104012_bib30","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/ng.855","article-title":"The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma","volume":"43","author":"Bott","year":"2011","journal-title":"Nat. Genet"},{"key":"10.1016\/j.critrevonc.2023.104012_bib31","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/modpathol.2015.65","article-title":"BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations","volume":"28","author":"Cigognetti","year":"2015","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.critrevonc.2023.104012_bib32","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1074\/mcp.RA119.001457","article-title":"Loss of BAP1 results in growth inhibition and enhances mesenchymal-epithelial transition in kidney tumor cells","volume":"18","author":"Chen","year":"2019","journal-title":"Mol. Cell Proteom."},{"key":"10.1016\/j.critrevonc.2023.104012_bib33","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/s41419-018-1206-5","article-title":"BAP1 regulates different mechanisms of cell death","volume":"9","author":"Affar","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.critrevonc.2023.104012_bib34","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/nature22798","article-title":"BAP1 regulates IP3R3-mediated Ca(2+) flux to mitochondria suppressing cell transformation","volume":"546","author":"Bononi","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2023.104012_bib35","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12013-011-9184-6","article-title":"An emerging model for BAP1's role in regulating cell cycle progression","volume":"60","author":"Eletr","year":"2011","journal-title":"Cell Biochem Biophys."},{"key":"10.1016\/j.critrevonc.2023.104012_bib36","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1038\/s41556-018-0178-0","article-title":"BAP1 links metabolic regulation of ferroptosis to tumour suppression","volume":"20","author":"Zhang","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.critrevonc.2023.104012_bib37","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1158\/2159-8290.CD-19-1220","article-title":"Biological mechanisms and clinical significance of BAP1 mutations in human cancer","volume":"10","author":"Carbone","year":"2020","journal-title":"Cancer Disco"},{"key":"10.1016\/j.critrevonc.2023.104012_bib38","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3390\/biology2010040","article-title":"BRCA1 and its network of interacting partners","volume":"2","author":"Christou","year":"2013","journal-title":"Biology"},{"key":"10.1016\/j.critrevonc.2023.104012_bib39","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/s41418-020-00709-4","article-title":"Roles and mechanisms of BAP1 deubiquitinase in tumor suppression","volume":"28","author":"Masclef","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.critrevonc.2023.104012_bib40","first-page":"19","article-title":"NF2\/Merlin inactivation and potential therapeutic targets in mesothelioma","author":"Sato","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2023.104012_bib41","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/embor.2012.11","article-title":"Merlin: a tumour suppressor with functions at the cell cortex and in the nucleus","volume":"13","author":"Li","year":"2012","journal-title":"EMBO Rep."},{"key":"10.1016\/j.critrevonc.2023.104012_bib42","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2174\/138920310791824011","article-title":"Merlin, a \"magic\" linker between extracellular cues and intracellular signaling pathways that regulate cell motility, proliferation, and survival","volume":"11","author":"Stamenkovic","year":"2010","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.critrevonc.2023.104012_bib43","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3008639","article-title":"Merlin deficiency predicts FAK inhibitor sensitivity: a synthetic lethal relationship","volume":"6","author":"Shapiro","year":"2014","journal-title":"Sci. Transl. Med"},{"key":"10.1016\/j.critrevonc.2023.104012_bib44","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1158\/1078-0432.CCR-16-1971","article-title":"Co-occurring mutations of tumor suppressor genes, LATS2 and NF2, in malignant pleural mesothelioma","volume":"23","author":"Tranchant","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2023.104012_bib45","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.1038\/onc.2012.5","article-title":"YAP induces malignant mesothelioma cell proliferation by upregulating transcription of cell cycle-promoting genes","volume":"31","author":"Mizuno","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2023.104012_bib46","first-page":"55","article-title":"ERS\/ESTS\/EACTS\/ESTRO guidelines for the management of malignant pleural mesothelioma","author":"Scherpereel","year":"2020","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.critrevonc.2023.104012_bib47","first-page":"12","article-title":"Mutational Profile of Malignant Pleural Mesothelioma (MPM) in the Phase II RAMES Study","author":"Pagano","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.critrevonc.2023.104012_bib48","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202013631","article-title":"KRAS signaling in malignant pleural mesothelioma","volume":"14","author":"Marazioti","year":"2022","journal-title":"EMBO Mol. Med"},{"key":"10.1016\/j.critrevonc.2023.104012_bib49","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1038\/onc.2013.351","article-title":"Overexpression and promoter mutation of the TERT gene in malignant pleural mesothelioma","volume":"33","author":"Tallet","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2023.104012_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.589929","article-title":"TERT-Regulation and Roles in Cancer Formation","volume":"11","author":"Dratwa","year":"2020","journal-title":"Front Immunol."},{"key":"10.1016\/j.critrevonc.2023.104012_bib51","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jmoldx.2017.10.002","article-title":"Heterogeneity of BRAF, NRAS, and TERT promoter mutational status in Multiple Melanomas and Association with MC1R genotype: findings from molecular and immunohistochemical analysis","volume":"20","author":"Pellegrini","year":"2018","journal-title":"J. Mol. Diagn."},{"key":"10.1016\/j.critrevonc.2023.104012_bib52","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1158\/1078-0432.CCR-19-3573","article-title":"Telomerase reverse transcriptase promoter mutations identify a genomically defined and highly aggressive human pleural mesothelioma subgroup","volume":"26","author":"Pirker","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2023.104012_bib53","doi-asserted-by":"crossref","first-page":"113673","DOI":"10.18632\/oncotarget.22817","article-title":"Large-scale copy number analysis reveals variations in genes not previously associated with malignant pleural mesothelioma","volume":"8","author":"Hylebos","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.critrevonc.2023.104012_bib54","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1186\/s12885-017-3382-6","article-title":"Whole exome sequencing of an asbestos-induced wild-type murine model of malignant mesothelioma","volume":"17","author":"Sneddon","year":"2017","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2023.104012_bib55","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/ajh.25460","article-title":"Diffuse large B-cell lymphoma: 2019 update on diagnosis, risk stratification, and treatment","volume":"94","author":"Liu","year":"2019","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.critrevonc.2023.104012_bib56","first-page":"5864","article-title":"MDM4 alternative splicing and implication in MDM4 targeted cancer therapies","volume":"11","author":"Wu","year":"2021","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.critrevonc.2023.104012_bib57","first-page":"828","article-title":"Inhibition of RPTOR overcomes resistance to EGFR inhibition in triple-negative breast cancer cells","volume":"52","author":"You","year":"2018","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.critrevonc.2023.104012_bib58","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/s41568-021-00367-9","article-title":"MYC protein interactors in gene transcription and cancer","volume":"21","author":"Lourenco","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.critrevonc.2023.104012_bib59","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/nrg2005","article-title":"Cancer epigenomics: DNA methylomes and histone-modification maps","volume":"8","author":"Esteller","year":"2007","journal-title":"Nat. Rev. Genet"},{"key":"10.1016\/j.critrevonc.2023.104012_bib60","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1158\/0008-5472.CAN-08-2586","article-title":"Epigenetic profiles distinguish pleural mesothelioma from normal pleura and predict lung asbestos burden and clinical outcome","volume":"69","author":"Christensen","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2023.104012_bib61","doi-asserted-by":"crossref","first-page":"9073","DOI":"10.1158\/0008-5472.CAN-09-1595","article-title":"Epigenetic profiles distinguish malignant pleural mesothelioma from lung adenocarcinoma","volume":"69","author":"Goto","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2023.104012_bib62","doi-asserted-by":"crossref","first-page":"2536187","DOI":"10.1155\/2017\/2536187","article-title":"SFRP tumour suppressor genes are potential plasma-based epigenetic biomarkers for malignant pleural mesothelioma","volume":"2017","author":"Cheng","year":"2017","journal-title":"Dis. Markers"},{"key":"10.1016\/j.critrevonc.2023.104012_bib63","doi-asserted-by":"crossref","first-page":"350","DOI":"10.21037\/tlcr.2017.06.06","article-title":"Targeting the epigenome in malignant pleural mesothelioma","volume":"6","author":"McLoughlin","year":"2017","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.critrevonc.2023.104012_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-981-15-8104-5_1","article-title":"Overview of histone modification","volume":"1283","author":"Zhang","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.critrevonc.2023.104012_bib65","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/JTO.0b013e318194f991","article-title":"A histone deacetylase inhibitor LBH589 downregulates XIAP in mesothelioma cell lines which is likely responsible for increased apoptosis with TRAIL","volume":"4","author":"Symanowski","year":"2009","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.critrevonc.2023.104012_bib66","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1158\/1078-0432.CCR-08-1579","article-title":"Valproate, in combination with pemetrexed and cisplatin, provides additional efficacy to the treatment of malignant mesothelioma","volume":"15","author":"Vandermeers","year":"2009","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.critrevonc.2023.104012_bib67","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1038\/nm.3947","article-title":"Loss of BAP1 function leads to EZH2-dependent transformation","volume":"21","author":"LaFave","year":"2015","journal-title":"Nat. Med"},{"key":"10.1016\/j.critrevonc.2023.104012_bib68","doi-asserted-by":"crossref","first-page":"335","DOI":"10.21037\/tlcr.2017.06.02","article-title":"Drug development against the hippo pathway in mesothelioma","volume":"6","author":"Woodard","year":"2017","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.critrevonc.2023.104012_bib69","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.omtn.2021.04.001","article-title":"MicroRNA-206 suppresses mesothelioma progression via the Ras signaling axis","volume":"24","author":"Singh","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.critrevonc.2023.104012_bib70","first-page":"13","article-title":"NF2 and Canonical Hippo-YAP pathway define distinct tumor subsets characterized by different immune deficiency and treatment implications in human pleural mesothelioma","author":"Yang","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.critrevonc.2023.104012_bib71","first-page":"21","article-title":"Dual inhibition of CDK4\/6 and PI3K\/AKT\/mTOR signaling impairs energy metabolism in MPM cancer cells","author":"Bonelli","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2023.104012_bib72","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.neo.2017.05.003","article-title":"Combined Inhibition of CDK4\/6 and PI3K\/AKT\/mTOR pathways induces a synergistic anti-tumor effect in malignant pleural mesothelioma cells","volume":"19","author":"Bonelli","year":"2017","journal-title":"Neoplasia"},{"key":"10.1016\/j.critrevonc.2023.104012_bib73","first-page":"1884","article-title":"Astaxanthin prevents against lipopolysaccharide-induced acute lung injury and sepsis via inhibiting activation of MAPK\/NF-kappaB","volume":"11","author":"Cai","year":"2019","journal-title":"Am. J. Transl. Res"},{"key":"10.1016\/j.critrevonc.2023.104012_bib74","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0105919","article-title":"MET and PI3K\/mTOR as a potential combinatorial therapeutic target in malignant pleural mesothelioma","volume":"9","author":"Kanteti","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.critrevonc.2023.104012_bib75","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1038\/bjc.2013.130","article-title":"Mutation analysis of the EGFR gene and downstream signalling pathway in histologic samples of malignant pleural mesothelioma","volume":"108","author":"Mezzapelle","year":"2013","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.critrevonc.2023.104012_bib76","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.lungcan.2020.12.028","article-title":"Expression of EGFR and conformational forms of EGFR in malignant pleural mesothelioma and its impact on survival","volume":"153","author":"Chia","year":"2021","journal-title":"Lung Cancer"},{"key":"10.1016\/j.critrevonc.2023.104012_bib77","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/S1470-2045(21)00404-6","article-title":"Gemcitabine with or without ramucirumab as second-line treatment for malignant pleural mesothelioma (RAMES): a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"22","author":"Pinto","year":"2021","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2023.104012_bib78","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s10456-017-9562-9","article-title":"Tumor angiogenesis and vascular normalization: alternative therapeutic targets","volume":"20","author":"Viallard","year":"2017","journal-title":"Angiogenesis"},{"key":"10.1016\/j.critrevonc.2023.104012_bib79","doi-asserted-by":"crossref","first-page":"574","DOI":"10.21037\/tlcr.2018.04.10","article-title":"Current chemotherapy strategies in malignant pleural mesothelioma","volume":"7","author":"de Gooijer","year":"2018","journal-title":"Transl. Lung Cancer Res"},{"key":"10.1016\/j.critrevonc.2023.104012_bib80","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1053\/j.seminoncol.2019.06.001","article-title":"Targeting angiogenesis for patients with unresectable malignant pleural mesothelioma","volume":"46","author":"Tsao","year":"2019","journal-title":"Semin Oncol."},{"key":"10.1016\/j.critrevonc.2023.104012_bib81","doi-asserted-by":"crossref","first-page":"126","DOI":"10.3389\/fonc.2020.00126","article-title":"Antiangiogeneic strategies in mesothelioma","volume":"10","author":"Nowak","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2023.104012_bib82","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1158\/0008-5472.CAN-15-1796","article-title":"Inhibition of PAI-1 limits tumor angiogenesis regardless of angiogenic stimuli in malignant pleural mesothelioma","volume":"76","author":"Takayama","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2023.104012_bib83","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","article-title":"New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer","volume":"20","author":"Dongre","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.critrevonc.2023.104012_bib84","first-page":"22","article-title":"The Epithelial-to-Mesenchymal Transition (EMT) in the development and metastasis of malignant pleural mesothelioma","author":"Ramundo","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2023.104012_bib85","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.lungcan.2019.11.013","article-title":"Detection of TGF-beta in pleural effusions for diagnosis and prognostic stratification of malignant pleural mesothelioma","volume":"139","author":"Stockhammer","year":"2020","journal-title":"Lung Cancer"},{"key":"10.1016\/j.critrevonc.2023.104012_bib86","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/1759-7714.13746","article-title":"Diagnostic value of microRNAs for malignant pleural mesothelioma: a mini-review","volume":"12","author":"Han","year":"2021","journal-title":"Thorac. Cancer"},{"key":"10.1016\/j.critrevonc.2023.104012_bib87","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3389\/fonc.2020.00105","article-title":"Manipulating microRNAs for the treatment of malignant pleural mesothelioma: past, present and future","volume":"10","author":"Reid","year":"2020","journal-title":"Front Oncol."},{"key":"10.1016\/j.critrevonc.2023.104012_bib88","doi-asserted-by":"crossref","first-page":"650","DOI":"10.3389\/fonc.2018.00650","article-title":"MicroRNAs for the DIagnosis and Management of Malignant Pleural Mesothelioma: A Literature Review","volume":"8","author":"Lo Russo","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2023.104012_bib89","doi-asserted-by":"crossref","first-page":"5661","DOI":"10.1038\/onc.2017.184","article-title":"LncRNA-mediated regulation of cell signaling in cancer","volume":"36","author":"Peng","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2023.104012_bib90","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.cell.2018.01.011","article-title":"Functional classification and experimental dissection of long noncoding RNAs","volume":"172","author":"Kopp","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2023.104012_bib91","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/cac2.12108","article-title":"LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer","volume":"41","author":"Tan","year":"2021","journal-title":"Cancer Commun."},{"key":"10.1016\/j.critrevonc.2023.104012_bib92","doi-asserted-by":"crossref","first-page":"313","DOI":"10.7754\/Clin.Lab.2016.160812","article-title":"Comprehensive analysis of lncRNA and mRNA expression profiles in lung cancer","volume":"63","author":"Chen","year":"2017","journal-title":"Clin. Lab"},{"key":"10.1016\/j.critrevonc.2023.104012_bib93","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070940","article-title":"Long non coding RNAs (lncRNAs) are dysregulated in Malignant Pleural Mesothelioma (MPM)","volume":"8","author":"Wright","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.critrevonc.2023.104012_bib94","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.1007\/s00018-020-03503-0","article-title":"Long non-coding RNA NEAT1-centric gene regulation","volume":"77","author":"Wang","year":"2020","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.critrevonc.2023.104012_bib95","article-title":"NEAT1: a novel cancer-related long non-coding RNA","volume":"50","author":"Yu","year":"2017","journal-title":"Cell Prolif."},{"key":"10.1016\/j.critrevonc.2023.104012_bib96","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/s12276-021-00621-y","article-title":"PAX8-AS1 knockdown facilitates cell growth and inactivates autophagy in osteoblasts via the miR-1252-5p\/GNB1 axis in osteoporosis.","volume":"53","author":"Huang","year":"2021","journal-title":"Exp. Mol. Med"},{"key":"10.1016\/j.critrevonc.2023.104012_bib97","doi-asserted-by":"crossref","first-page":"5499963","DOI":"10.1155\/2021\/5499963","article-title":"Overexpression of PAX8-AS1 inhibits malignant phenotypes of papillary thyroid carcinoma cells via miR-96-5p\/PKN2 axis","volume":"2021","author":"Zhou","year":"2021","journal-title":"Int. J. Endocrinol."},{"key":"10.1016\/j.critrevonc.2023.104012_bib98","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1002\/jcb.27586","article-title":"Clinical significance of serum DRAM1 mRNA, ARSA mRNA, hsa-miR-2053 and lncRNA-RP1-86D1.3 axis expression in malignant pleural mesothelioma","volume":"120","author":"Matboli","year":"2019","journal-title":"J. Cell Biochem."},{"key":"10.1016\/j.critrevonc.2023.104012_bib99","first-page":"19","article-title":"In silico and in vitro analyses of LncRNAs as potential regulators in the transition from the epithelioid to sarcomatoid histotype of malignant pleural mesothelioma (MPM)","author":"Singh","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2023.104012_bib100","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/1476-4598-13-119","article-title":"GAS5 long non-coding RNA in malignant pleural mesothelioma","volume":"13","author":"Renganathan","year":"2014","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.critrevonc.2023.104012_bib101","article-title":"miR-625-3p and lncRNA GAS5 in liquid biopsies for predicting the outcome of malignant pleural mesothelioma patients treated with neo-adjuvant chemotherapy and surgery","volume":"5","author":"Kresoja-Rakic","year":"2019","journal-title":"Noncoding RNA"},{"key":"10.1016\/j.critrevonc.2023.104012_bib102","doi-asserted-by":"crossref","first-page":"609","DOI":"10.3389\/fonc.2019.00609","article-title":"PVT1 promotes cancer progression via MicroRNAs","volume":"9","author":"Wang","year":"2019","journal-title":"Front Oncol."},{"key":"10.1016\/j.critrevonc.2023.104012_bib103","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1097\/JTO.0000000000000202","article-title":"Frequent coamplification and cooperation between C-MYC and PVT1 oncogenes promote malignant pleural mesothelioma","volume":"9","author":"Riquelme","year":"2014","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.critrevonc.2023.104012_bib104","first-page":"47","article-title":"Downregulation of lncRNA PVT1 inhibits proliferation and migration of mesothelioma cells by targeting FOXM1","author":"Fujii","year":"2022","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.critrevonc.2023.104012_bib105","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1515\/med-2021-0383","article-title":"MALAT1 promotes malignant pleural mesothelioma by sponging miR-141-3p","volume":"16","author":"Wang","year":"2021","journal-title":"Open Med."},{"key":"10.1016\/j.critrevonc.2023.104012_bib106","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.615234","article-title":"Combined analysis of RNA sequence and microarray data reveals a competing endogenous RNA network as novel prognostic markers in malignant pleural mesothelioma","volume":"11","author":"Duan","year":"2021","journal-title":"Front Oncol."},{"key":"10.1016\/j.critrevonc.2023.104012_bib107","article-title":"Long non-coding RNA PCAT6 induces M2 polarization of macrophages in cholangiocarcinoma via modulating miR-326 and RhoA-ROCK signaling pathway","volume":"10","author":"Tu","year":"2020","journal-title":"Front Oncol."},{"key":"10.1016\/j.critrevonc.2023.104012_bib108","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.bbrc.2018.05.143","article-title":"Effect of long non-coding RNA H19 on oxidative stress and chemotherapy resistance of CD133+ cancer stem cells via the MAPK\/ERK signaling pathway in hepatocellular carcinoma","volume":"502","author":"Ding","year":"2018","journal-title":"Biochem Biophys. Res. Commun."},{"key":"10.1016\/j.critrevonc.2023.104012_bib109","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.2147\/DDDT.S332847","article-title":"Ketamine induces ferroptosis of liver cancer cells by targeting lncRNA PVT1\/miR-214-3p\/GPX4","volume":"15","author":"He","year":"2021","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.critrevonc.2023.104012_bib110","article-title":"BAP1-Related ceRNA (NEAT1\/miR-10a-5p\/SERPINE1) promotes proliferation and migration of kidney cancer cells","volume":"12","author":"Liu","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2023.104012_bib111","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1159\/000491811","article-title":"LncRNA NEAT1 promotes deterioration of hepatocellular carcinoma based on in vitro experiments, data mining, and RT-qPCR analysis","volume":"48","author":"Ling","year":"2018","journal-title":"Cell Physiol. Biochem."},{"key":"10.1016\/j.critrevonc.2023.104012_bib112","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s12935-020-1158-6","article-title":"MYC-regulated lncRNA NEAT1 promotes B cell proliferation and lymphomagenesis via the miR-34b-5p-GLI1 pathway in diffuse large B-cell lymphoma","volume":"20","author":"Qian","year":"2020","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.critrevonc.2023.104012_bib113","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ebiom.2018.10.004","article-title":"Long noncoding RNA PCAT6 functions as an oncogene by binding to EZH2 and suppressing LATS2 in non-small-cell lung cancer","volume":"37","author":"Shi","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.critrevonc.2023.104012_bib114","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1002\/jcb.26591","article-title":"MiR-15b\/HOTAIR\/p53 form a regulatory loop that affects the growth of glioma cells","volume":"119","author":"Sun","year":"2018","journal-title":"J. Cell Biochem."},{"key":"10.1016\/j.critrevonc.2023.104012_bib115","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/1476-4598-13-156","article-title":"Long non-coding RNA HOTAIR, a c-Myc activated driver of malignancy, negatively regulates miRNA-130a in gallbladder cancer","volume":"13","author":"Ma","year":"2014","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.critrevonc.2023.104012_bib116","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1158\/0008-5472.CAN-18-2170","article-title":"Temozolomide treatment induces lncRNA MALAT1 in an NF-kappaB and p53 codependent manner in glioblastoma","volume":"79","author":"Voce","year":"2019","journal-title":"Cancer Res"},{"key":"10.1016\/j.critrevonc.2023.104012_bib117","doi-asserted-by":"crossref","first-page":"9138","DOI":"10.1002\/cam4.3570","article-title":"LncRNA MALAT1 accelerates non-small cell lung cancer progression via regulating miR-185-5p\/MDM4 axis","volume":"9","author":"Wang","year":"2020","journal-title":"Cancer Med."},{"key":"10.1016\/j.critrevonc.2023.104012_bib118","doi-asserted-by":"crossref","first-page":"4376","DOI":"10.1158\/1078-0432.CCR-16-2185","article-title":"Identification of a novel SYK\/c-MYC\/MALAT1 signaling pathway and its potential therapeutic value in Ewing Sarcoma","volume":"23","author":"Sun","year":"2017","journal-title":"Clin. Cancer Res"},{"key":"10.1016\/j.critrevonc.2023.104012_bib119","doi-asserted-by":"crossref","first-page":"18724","DOI":"10.1002\/jcb.29182","article-title":"Upregulation of miR-675-5p induced by lncRNA H19 was associated with tumor progression and development by targeting tumor suppressor p53 in non-small cell lung cancer","volume":"120","author":"Zheng","year":"2019","journal-title":"J. Cell Biochem."},{"key":"10.1016\/j.critrevonc.2023.104012_bib120","first-page":"12400","article-title":"c-Myc-activated long non-coding RNA H19 downregulates miR-107 and promotes cell cycle progression of non-small cell lung cancer","volume":"8","author":"Cui","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.critrevonc.2023.104012_bib121","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.dld.2019.08.012","article-title":"Long non-coding RNA GAS5 inhibits migration and invasion in gastric cancer via interacting with p53 protein","volume":"52","author":"Liu","year":"2020","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.critrevonc.2023.104012_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2022.105321","article-title":"Propofol inhibits proliferation and migration of glioma cells by up-regulating lncRNA GAS5","volume":"80","author":"Cheng","year":"2022","journal-title":"Toxicol. Vitr."},{"key":"10.1016\/j.critrevonc.2023.104012_bib123","doi-asserted-by":"crossref","first-page":"4723","DOI":"10.1038\/s41388-018-0310-4","article-title":"LncRNA PVT1 regulates triple-negative breast cancer through KLF5\/beta-catenin signaling","volume":"37","author":"Tang","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2023.104012_bib124","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1158\/1535-7163.MCT-15-0707","article-title":"Long noncoding RNA PVT1 promotes non-small cell lung cancer cell proliferation through epigenetically regulating LATS2 expression","volume":"15","author":"Wan","year":"2016","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.critrevonc.2023.104012_bib125","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s12943-020-01277-4","article-title":"The PVT1 lncRNA is a novel epigenetic enhancer of MYC, and a promising risk-stratification biomarker in colorectal cancer","volume":"19","author":"Shigeyasu","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.critrevonc.2023.104012_bib126","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/jb\/mvaa005","article-title":"C-Myc-activated long non-coding RNA PVT1 enhances the proliferation of cervical cancer cells by sponging miR-486-3p","volume":"167","author":"Wang","year":"2020","journal-title":"J. Biochem."},{"key":"10.1016\/j.critrevonc.2023.104012_bib127","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1007\/s00432-017-2478-3","article-title":"A novel interplay between HOTAIR and DNA methylation in osteosarcoma cells indicates a new therapeutic strategy","volume":"143","author":"Li","year":"2017","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2023.104012_bib128","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13046-020-01610-1","article-title":"LncRNA HOTAIR-mediated MTHFR methylation inhibits 5-fluorouracil sensitivity in esophageal cancer cells","volume":"39","author":"Zhang","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2023.104012_bib129","first-page":"S58","article-title":"Evaluation of MALAT1 promoter DNA methylation patterns in early colorectal lesions and tumors","volume":"12","author":"Chaleshi","year":"2019","journal-title":"Gastroenterol. Hepatol. Bed Bench"},{"key":"10.1016\/j.critrevonc.2023.104012_bib130","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1038\/onc.2016.391","article-title":"Metformin alters DNA methylation genome-wide via the H19\/SAHH axis","volume":"36","author":"Zhong","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.critrevonc.2023.104012_bib131","doi-asserted-by":"crossref","unstructured":"Zhao D., Li Y., Yu MJRA: LncRNA GAS5 facilitates nasopharyngeal carcinoma progression through epigenetically silencing PTEN via EZH2. 2019, 9:31691\u201331698.","DOI":"10.1039\/C9RA05405G"},{"key":"10.1016\/j.critrevonc.2023.104012_bib132","first-page":"6403","article-title":"NEAT1 promotes cell proliferation in multiple myeloma by activating PI3K\/AKT pathway","volume":"22","author":"Xu","year":"2018","journal-title":"Eur. Rev. Med. Pharm. Sci."},{"key":"10.1016\/j.critrevonc.2023.104012_bib133","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/s41392-021-00466-x","article-title":"SOX9-transactived long non-coding RNA NEAT1 promotes the self-renewal of liver cancer stem cells through PKA\/Hippo signaling","volume":"6","author":"Cheng","year":"2021","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.critrevonc.2023.104012_bib134","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1080\/15384047.2018.1450119","article-title":"LncRNA NEAT1\/let-7a-5p axis regulates the cisplatin resistance in nasopharyngeal carcinoma by targeting Rsf-1 and modulating the Ras-MAPK pathway","volume":"19","author":"Liu","year":"2018","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.critrevonc.2023.104012_bib135","first-page":"3358","article-title":"Silencing long noncoding RNA NEAT1 suppresses the tumorigenesis of infantile hemangioma by competitively binding miR33a5p to stimulate HIF1alpha\/NFkappaB pathway","volume":"22","author":"Yu","year":"2020","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.critrevonc.2023.104012_bib136","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.bbrc.2019.10.136","article-title":"LncRNA PCAT6 promotes tumor progression in osteosarcoma via activation of TGF-beta pathway by sponging miR-185-5p","volume":"521","author":"Zhu","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.critrevonc.2023.104012_bib137","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.bbamcr.2019.02.004","article-title":"HOTAIR\/miR-326\/FUT6 axis facilitates colorectal cancer progression through regulating fucosylation of CD44 via PI3K\/AKT\/mTOR pathway","volume":"1866","author":"Pan","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.critrevonc.2023.104012_bib138","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/s41416-020-01091-1","article-title":"Long noncoding RNA HOTAIR regulates the invasion and metastasis of prostate cancer by targeting hepaCAM","volume":"124","author":"Li","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.critrevonc.2023.104012_bib139","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13014-018-1153-4","article-title":"Overexpression of HOTAIR leads to radioresistance of human cervical cancer via promoting HIF-1alpha expression","volume":"13","author":"Li","year":"2018","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.critrevonc.2023.104012_bib140","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13046-020-01562-6","article-title":"Exosomal MALAT1 sponges miR-26a\/26b to promote the invasion and metastasis of colorectal cancer via FUT4 enhanced fucosylation and PI3K\/Akt pathway","volume":"39","author":"Xu","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2023.104012_bib141","doi-asserted-by":"crossref","first-page":"5805","DOI":"10.1002\/jcp.26357","article-title":"Study on mechanism about long noncoding RNA MALAT1 affecting pancreatic cancer by regulating Hippo-YAP signaling","volume":"233","author":"Zhou","year":"2018","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.critrevonc.2023.104012_bib142","doi-asserted-by":"crossref","first-page":"806","DOI":"10.4161\/cbt.28584","article-title":"MALAT1 promotes the proliferation and metastasis of gallbladder cancer cells by activating the ERK\/MAPK pathway","volume":"15","author":"Wu","year":"2014","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.critrevonc.2023.104012_bib143","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1038\/s41418-019-0288-7","article-title":"MALAT1-KTN1-EGFR regulatory axis promotes the development of cutaneous squamous cell carcinoma","volume":"26","author":"Zhang","year":"2019","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.critrevonc.2023.104012_bib144","doi-asserted-by":"crossref","first-page":"6619730","DOI":"10.1155\/2021\/6619730","article-title":"Overexpression of long noncoding RNA H19 downregulates miR-140-5p and activates PI3K\/AKT signaling pathway to promote invasion, migration and epithelial-mesenchymal transition of ovarian cancer cells","volume":"2021","author":"Xu","year":"2021","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.critrevonc.2023.104012_bib145","first-page":"3365","article-title":"Long non-coding RNA H19 promotes the migration and invasion of colon cancer cells via MAPK signaling pathway","volume":"16","author":"Yang","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.critrevonc.2023.104012_bib146","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4149\/neo_2019_190121N61","article-title":"LncRNA H19 promotes glioma angiogenesis through miR-138\/HIF-1alpha\/VEGF axis","volume":"67","author":"Liu","year":"2020","journal-title":"Neoplasma"},{"key":"10.1016\/j.critrevonc.2023.104012_bib147","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.prp.2018.12.013","article-title":"lncRNAPVT1 targets miR-152 to enhance chemoresistance of osteosarcoma to gemcitabine through activating c-MET\/PI3K\/AKT pathway","volume":"215","author":"Sun","year":"2019","journal-title":"Pathol. Res. Pr."},{"key":"10.1016\/j.critrevonc.2023.104012_bib148","first-page":"21","article-title":"lncRNA PVT1 promotes metastasis of non-small cell lung cancer through EZH2-Mediated activation of Hippo\/NOTCH1 signaling pathways","volume":"23","author":"Zeng","year":"2021","journal-title":"Cell J."},{"key":"10.1016\/j.critrevonc.2023.104012_bib149","doi-asserted-by":"crossref","first-page":"8229","DOI":"10.1111\/jcmm.16700","article-title":"LncRNA PVT1 promotes the progression of ovarian cancer by activating TGF-beta pathway via miR-148a-3p\/AGO1 axis","volume":"25","author":"Wu","year":"2021","journal-title":"J. Cell Mol. Med"},{"key":"10.1016\/j.critrevonc.2023.104012_bib150","doi-asserted-by":"crossref","DOI":"10.1177\/1533033821990074","article-title":"Upregulation of long noncoding RNA_GAS5 suppresses cell proliferation and metastasis in laryngeal cancer via regulating PI3K\/AKT\/mTOR signaling pathway","volume":"20","author":"Liu","year":"2021","journal-title":"Technol. Cancer Res. Treat."},{"key":"10.1016\/j.critrevonc.2023.104012_bib151","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1186\/s13046-019-1329-2","article-title":"Long non-coding RNA GAS5 inhibits DDP-resistance and tumor progression of epithelial ovarian cancer via GAS5-E2F4-PARP1-MAPK axis","volume":"38","author":"Long","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2023.104012_bib152","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.biopha.2017.10.157","article-title":"Long non-coding RNA GAS5 antagonizes the chemoresistance of pancreatic cancer cells through down-regulation of miR-181c-5p","volume":"97","author":"Gao","year":"2018","journal-title":"Biomed. Pharm."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842823001002?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842823001002?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T19:50:20Z","timestamp":1760903420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842823001002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":152,"alternative-id":["S1040842823001002"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2023.104012","relation":{},"ISSN":["1040-8428"],"issn-type":[{"type":"print","value":"1040-8428"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LncRNAs and related molecular basis in malignant pleural mesothelioma: Challenges and potential","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2023.104012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104012"}}